XML 49 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue Recognition and Collaborative Arrangements (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue Recognition and Collaborative Arrangements    
Total net revenue $ 78,678 $ 55,183
GSK    
Revenue Recognition and Collaborative Arrangements    
Total net revenue 78,678 55,183
GSK | Royalty revenue from a related party    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 82,134 58,639
Less: amortization of capitalized fees paid to a related party (3,456) (3,456)
GSK | RELVAR/BREO    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 56,149 42,740
GSK | ANORO    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 9,850 8,570
GSK | TRELEGY    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party $ 16,135 $ 7,329